Clinical trial

Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic…

NCT00295737 · Fraunhofer-Institute of Toxicology and Experimental Medicine, Other · Terminated

Key facts

NCT number NCT00295737
Title Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma
Official title 05/04 IMHOTEP-1 FHG: Ex Vivo Effect of an Immunotoxin on Activated Human Macrophages From Atopics After Segmental Instillation of Allergen and Endotoxin
Lead sponsor Fraunhofer-Institute of Toxicology and Experimental Medicine, Other
Status Terminated
Study type Interventional
Conditions Atopy, Rhinitis, Bronchial Asthma
Intervention type Procedure
Interventions bronchoscopy, allergen/endotoxin instillation
Enrollment 8
Start date Feb 1, 2006
Primary completion Jan 1, 2008
Completion Jan 1, 2008
First posted Feb 24, 2006
Last update posted Jan 16, 2008
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies